Stay updated on KZR-616 in PM and DM Open-label Extension Clinical Trial
Sign up to get notified when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.

Latest updates to the KZR-616 in PM and DM Open-label Extension Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record for the KZR-616 open-label extension study is displayed, including its study design, eligibility criteria, treatment, outcome measures, locations, and record history.SummaryDifference46%

- Check13 days agoChange DetectedThe displayed ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0, while the study page still shows a 403 Forbidden error instead of study details.SummaryDifference0.2%

- Check27 days agoChange DetectedA sitewide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” was added. The displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study content with a generic error screen. This reflects an access issue rather than a content update.SummaryDifference17%

- Check62 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the prior Revision: v3.6.6. This update reflects a revision to the page's documentation/versioning, without changing any study details presented to users.SummaryDifference0.1%

Stay in the know with updates to KZR-616 in PM and DM Open-label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.